Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjiang Xu

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 16, 2017
The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing micePeijin Li, Suning Li, Hongmei Gu, et al.
European Journal of Medicinal Chemistry|May 15, 2023
Discovery, optimization and biological evaluation of novel HBsAg production inhibitorsLi Zhang, Xingfeng Ge, Hui Jin, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2023
Discovery of imidazo[1,2-b]pyridazine macrocyclic derivatives as novel ALK inhibitors capable of combating multiple resistant mutantsXiaofei Xiao, Yunsheng Xu, Xihua Yu, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2023
Design, synthesis and biological evaluation of novel N-(methyl-d<sub>3</sub>) pyridazine-3-carboxamide derivatives as TYK2 inhibitorsFei Liu, Bin Wang, Yanlong Liu, et al.
European Journal of Medicinal Chemistry|October 29, 2017
Rapid generation of a novel DPP-4 inhibitor with long-acting properties: SAR study and PK/PD evaluationHui Xie, Shaogao Zeng, Yuwen He, et al.
European Journal of Medicinal Chemistry|September 3, 2013
Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimizationHui Xie, Lili Zeng, Shaogao Zeng, et al.
Bioorganic & Medicinal Chemistry|December 18, 2019
Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitorsJing Ren, Wei Shi, Damin Zhao, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Novel TYK2 Inhibitors with an <i>N</i>-(Methyl-<i>d</i> <sub>3</sub>)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune DiseasesFei Liu, Bin Wang, Yanlong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2015
C-Aryl glucoside SGLT2 inhibitors containing a biphenyl motif as potential anti-diabetic agentsYuyang Ding, Liufeng Mao, Dengfeng Xu, et al.
European Journal of Medicinal Chemistry|November 26, 2010
The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetesJifeng Deng, Li Peng, Guicheng Zhang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 16, 2017
The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing micePeijin Li, Suning Li, Hongmei Gu, et al.
European Journal of Medicinal Chemistry|May 15, 2023
Discovery, optimization and biological evaluation of novel HBsAg production inhibitorsLi Zhang, Xingfeng Ge, Hui Jin, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2023
Discovery of imidazo[1,2-b]pyridazine macrocyclic derivatives as novel ALK inhibitors capable of combating multiple resistant mutantsXiaofei Xiao, Yunsheng Xu, Xihua Yu, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2023
Design, synthesis and biological evaluation of novel N-(methyl-d<sub>3</sub>) pyridazine-3-carboxamide derivatives as TYK2 inhibitorsFei Liu, Bin Wang, Yanlong Liu, et al.
European Journal of Medicinal Chemistry|October 29, 2017
Rapid generation of a novel DPP-4 inhibitor with long-acting properties: SAR study and PK/PD evaluationHui Xie, Shaogao Zeng, Yuwen He, et al.
European Journal of Medicinal Chemistry|September 3, 2013
Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimizationHui Xie, Lili Zeng, Shaogao Zeng, et al.
Bioorganic & Medicinal Chemistry|December 18, 2019
Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitorsJing Ren, Wei Shi, Damin Zhao, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Novel TYK2 Inhibitors with an <i>N</i>-(Methyl-<i>d</i> <sub>3</sub>)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune DiseasesFei Liu, Bin Wang, Yanlong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2015
C-Aryl glucoside SGLT2 inhibitors containing a biphenyl motif as potential anti-diabetic agentsYuyang Ding, Liufeng Mao, Dengfeng Xu, et al.
European Journal of Medicinal Chemistry|November 26, 2010
The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetesJifeng Deng, Li Peng, Guicheng Zhang, et al.
Pageof 4